icer semaglutide Obesity drugs may be pricey, but they're also cost-effective, analysis finds Weight-loss drugs becoming better value

Patients should not try to taper off faster than 4 weeks

even using the same region back-to-back may cause issues

Nat Med 22(8):879888

Preclinical and clinical studies examining multi-receptor agonists have reported changes in liver fat measurements, hepatic triglyceride content, and biochemical markers associated with liver metabolism

A high B12 with an entirely normal blood count is far less concerning than one sitting next to abnormal counts

The percentage of patients achieving clinically meaningful weight loss was also significantly higher with semaglutide: 44% of patients on semaglutide 0.5 mg reached 5% weight loss , compared with 23% on dulaglutide 0.75 mg